Total pathologic complete response (tpCR) and event-free survival (EFS) with subcutaneous (SC) or intravenous (IV) trastuzumab in HER2-positive early breast cancer (EBC).
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Total pathologic complete response (tpCR) and event-free survival (EFS) with subcutaneous (SC) or intravenous (IV) trastuzumab in HER2-positive early breast cancer (EBC). |
| Type de publication | Journal Article |
| Year of Publication | 2015 |
| Auteurs | Jackisch C, Hegg R, Stroyakovskiy D, Ahn JSeok, Melichar B, Chen S-C, Crepelle-Flechais A, Heinzmann D, Shing M, Pivot XB |
| Journal | JOURNAL OF CLINICAL ONCOLOGY |
| Volume | 33 |
| Date Published | MAY 20 |
| Type of Article | Meeting Abstract |
| ISSN | 0732-183X |
| DOI | 10.1200/jco.2015.33.15_suppl.585 |